ClinicalTrials.gg
CompletedNCT02213198Updated Feb 21, 2019Results posted

Improving Transitional Care Experiences in Mental Health

An interventional study of Engagement focused care and Standard Care in Standard Treatment Versus Engagement Focused Treatment, sponsored by The University of Texas Health Science Center at San Antonio. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-21.

Sponsored by The University of Texas Health Science Center at San Antonio · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
465
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The cost of serious mental illness (SMI) in the U.S. is $317 billion annually. This translates to more than $1000 for every man, women, and child in the U.S. Hospitalization and Emergency Room (ER) visits have the highest costs. Outpatient services are overburdened. There is a push to get people out of hospitals quickly, while they are still quite ill. These factors cause patients to be lost in the transition from inpatient to outpatient care. Many individuals are repeatedly rehospitalized or continue to clog emergency rooms in an attempt to receive care. The importance of transitional care between inpatient/ER facilities and outpatient services to prevent this revolving door phenomenon has been continually stressed. There is little research on the best way to accomplish smooth transition to outpatient care. We developed a 90-day transitional care clinic (TCC) to address this need. We propose a randomized treatment outcome study comparing two transitional service packages within our TCC: a Standard Care package versus an Engagement-Focused package that features a novel intake procedure and a Shared Decision-Making intervention: Access Group is an intake procedure designed to address many of the problems of traditional approaches to post-acute treatment engagement, including failure of patients to reach intake appointments. Shared Decision-Making (SDM) is a structured approach to provider-patient communication that has been shown to increase patient involvement in care and improve outcomes. Despite SMI patients' desire to be more involved in their treatment decisions and promising early evidence of SDM's effectiveness in SMI, SDM has not been systematically evaluated in transitional psychiatric care. In the proposed study, patients referred to TCC will be randomized to either Engagement-focused Care or Standard Care. The relative benefit of these two approaches will be evaluated in 300 individuals who will be randomized to these two treatments in a 2:1 ratio. We hypothesize that attendance at appointments, reported satisfaction, shared decision making and quality of life will be higher for engagement focused care. The new treatment package is designed to get individuals into treatment quickly and to teach them how to be good consumers of mental health treatments going forward.

Read the detailed description

Aim 1: To compare EFC to SC with respect to linkage to TCC services. Hypothesis A: Patients referred to EFC will exhibit a significantly greater rate of attendance at their TCC intake appointment than SC patients.

Aim 2: To compare EFC to SC with respect to patient participation in outpatient treatment.

Hypothesis B: Patients referred to EFC will report significantly greater shared decision-making in their TCC prescriber appointments than SC patients.

Hypothesis C: Patients referred to EFC will exhibit significantly greater attendance at post-intake scheduled TCC appointments than SC patients.

Hypothesis D: Patients referred to EFC will exhibit a significantly greater rate of attendance at initial post-TCC scheduled mental health appointments than SC patients.

Aim 3: To compare Engagement-focused Care (EFC) to Standard Care (SC) with respect to patients' long term quality of life.

Hypothesis E: Patients who receive EFC will exhibit significantly greater quality of life than SC patients six months after TCC termination.

02

Conditions studied

  • Standard Treatment Versus Engagement Focused Treatment

Keywords

  • Serious mental illness transitions shared decision making
03

In context

Lead sponsor

The University of Texas Health Science Center at San Antonio is the lead sponsor of 443 studies on the registry; 88 are open to participants now.

Of its 64 completed or terminated interventional studies of FDA-regulated products, 35 (55%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Serious mental illness including (schizophrenia, schizoaffective disorder, mood disorders, anxiety disorders), referral from inpatient psychiatric unit or emergency service at the time of discharge to the Transitional Care Clinic, ability to sign informed consent

Exclusion criteria

Exclusion Criteria:

  • Unable to complete assessments
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
465 participants (actual)

Study arms

  • Experimental
    Engagement Focused Care

    Engagement Focused Care which includes all components of standard treatment plus both group Access intake process with its flexibility of scheduling and the SDM intervention

    Behavioral: Engagement focused care

  • Active comparator
    Standard Care

    Standard Care includes individual intake appointments which are traditional in outpatient service and all services of the clinic including counseling, access to a prescriber, care coordination, and access to home visits.

    Behavioral: Standard Care

Interventions

  • BehavioralEngagement focused care

    Engagement focused care includes a group intake appointment called Access group with flexible scheduling allowing ease of rescheduling and access as soon as the same day, as well as Shared Decision Making coaching. For Shared Decision Making, a coach meets with the person prior to or following appointments with the prescriber to assist the person regarding what to ask, what to tell, to review options, and to foster choice.

  • BehavioralStandard Care

    Standard treatment provided by a university based transitional care clinic, with individual intakes and follow-ups for medication/therapy scheduled as soon as possible from intake but at least 1 week away-no prioritization of cases

06

What researchers measure

Primary outcomes

  1. Subjective Quality of Life

    The Quality of Life Interview (QOLI; 91) is a 45-minute structured interview that assesses quality of life in the domains of family, social relations, leisure activities, finances, legal/safety issues, work/school, and health. It is one of the most psychometrically sound QoL instruments for use in mental illness. The subjective scale assesses quality of life from the perspective of the patient. Subjective QOL = Mean of items 1,3,8,9,11,13,16,18,20,21 . Scores range from 1-7. Higher scores indicate better quality of life

    Time frame: baseline, 3 months and 6 months

  2. Engagement in Treatment

    Whether patient kept appointment post TCC

    Time frame: 6 months

07

Results

Posted Mar 15, 2017

Participant flow

Baseline
Participant flow — Baseline
MilestoneEngagement Focused CareStandard Care
Started306159
Completed218108
Not completed8851
Withdrew: No show for intake79
Withdrew: Withdrawal by subject3411
Withdrew: Transferred out of clinic79
Withdrew: Lost to follow-up4021
Withdrew: Incarcerated,violent01
Follow up 1 3 Mos Post BL End of TCC tx
Participant flow — Follow up 1 3 Mos Post BL End of TCC tx
MilestoneEngagement Focused CareStandard Care
Started218108
Completed12567
Not completed9341
Withdrew: Withdrawal by subject44
Withdrew: Rehab/incarceration/violence32
Withdrew: Death10
Withdrew: Lost to follow-up6825
Withdrew: Unable to contact at 3 but got 6 post dc1710
Follow up 2 6 Months Post TCC Treatment
Participant flow — Follow up 2 6 Months Post TCC Treatment
MilestoneEngagement Focused CareStandard Care
Started12567
Completed10260
Not completed237
Withdrew: Lost to follow-up237

Outcome measures

PrimarySubjective Quality of Life

The Quality of Life Interview (QOLI; 91) is a 45-minute structured interview that assesses quality of life in the domains of family, social relations, leisure activities, finances, legal/safety issues, work/school, and health. It is one of the most psychometrically sound QoL instruments for use in mental illness. The subjective scale assesses quality of life from the perspective of the patient. Subjective QOL = Mean of items 1,3,8,9,11,13,16,18,20,21 . Scores range from 1-7. Higher scores indicate better quality of life

Time frame:
baseline, 3 months and 6 months
Reported as:
Mean · units on a scale
Subjective Quality of Life
units on a scaleEngagement Focused CareStandard Care
Baseline3.9 ± 1.13.8 ± 1.1
TCC Discharge at 3 months4.3 ± 1.14.0 ± 1.0
Follow up 6 mos post TCC4.5 ± 1.14.2 ± 1.0
PrimaryEngagement in Treatment

Whether patient kept appointment post TCC

Time frame:
6 months
Reported as:
Count of participants · Participants
Engagement in Treatment
ParticipantsEngagement Focused CareStandard Care
Engagement in Treatment7840

Adverse events

Collected over 9-12 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Engagement Focused Care—0/306 (0%)0/306 (0%)
Standard Care—0/159 (0%)0/159 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Engagement Focused CareStandard CareTotal
<=18 years000
Between 18 and 65 years219107326
>=65 years000
Age, Continuous
Age, Continuous(years)Engagement Focused CareStandard CareTotal
Mean37.1 ± 11.439.9 ± 13.138 ± 11.9
Sex: Female, Male
Sex: Female, Male(Participants)Engagement Focused CareStandard CareTotal
Female12356179
Male9651147
Region of Enrollment
Region of Enrollment(participants)Engagement Focused CareStandard CareTotal
United States219107326
08

Study locations

1 site
  • UTHSCSA
    San Antonio, Texas 78229, United States
09

References and documents

Individual participant data

Plan to share: Yes — Deidentified data provided by PI as requested velligand@uthscsa.edu

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2014, a primary completion of Jul 2016 and a completion of Jul 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Mar 2017, 8 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 7, 2014
First posted
Aug 11, 2014
Start
Aug 2014
Primary completionActual
Jul 2016
CompletionActual
Jul 2016
Results first posted
Mar 15, 2017
Last update
Feb 21, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02213198
Collaborators
Patient-Centered Outcomes Research Institute
Responsible party
Sponsor
First posted
Aug 11, 2014
Start date
Aug 2014
Primary completion
Jul 2016
Completion
Jul 2016
Results posted
Mar 15, 2017
Last update
Feb 21, 2019

Study contacts

Dawn I Velligan, PhD
principal investigator · University of Texas

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion